Here Comes the Booming Chinese Biotech Sector
Odd Lots
00:00
Biotech Battleground: China vs. the U.S.
This chapter examines China's rapid progress in the biotechnology sector in comparison to the U.S., highlighting efficient drug development processes and the impact of U.S. regulations on collaboration. It discusses the interplay of AI innovations in drug development and the competitive landscape affected by talent dynamics and protectionist policies. The conversation also critiques Europe's pharmaceutical industry relative to the U.S. and speculates on China's future ambitions in the global market.
Transcript
Play full episode
